This research has also highlighted issues associated with using ACTA2 (the gene encoding SMA) expression as the sole criteria for identifying CAFs or even myCAF, as ACTA2+ smooth muscle cells and pericytes are also commonly found in the tumour microenvironment and these cells exhibit higher ACTA2 expression levels than CAFs [6]. The gene discussed is ACTA2; the disease is neoplasm.